{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:54:50Z","timestamp":1793652890715,"version":"4.5.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG063801"],"award-info":[{"award-number":["R01 AG063801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA242003"],"award-info":[{"award-number":["R01 CA242003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA054174"],"award-info":[{"award-number":["P30 CA054174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG063801"],"award-info":[{"award-number":["R01 AG063801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA242003"],"award-info":[{"award-number":["R01 CA242003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K01 AA024174"],"award-info":[{"award-number":["K01 AA024174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA028035"],"award-info":[{"award-number":["R01 AA028035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210208"],"award-info":[{"award-number":["RP210208"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000161","name":"United States Department of Commerce | National Institute of Standards and Technology","doi-asserted-by":"publisher","award":["60NANB24D117"],"award-info":[{"award-number":["60NANB24D117"]}],"id":[{"id":"10.13039\/100000161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-025-00811-7","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:03:57Z","timestamp":1738299837000},"page":"386-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["A BCL-xL\/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-681X","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6533-2569","authenticated-orcid":false,"given":"Natacha","family":"Jn-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-4590","authenticated-orcid":false,"given":"Yonghan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivasulu","family":"Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli S.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Zhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-6093","authenticated-orcid":false,"given":"Xian-Ming","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hromas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8106-6663","authenticated-orcid":false,"given":"Guangrong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-7677","authenticated-orcid":false,"given":"Liya","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2400-6461","authenticated-orcid":false,"given":"Daohong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"811_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"811_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813\u2013827 (2019).","journal-title":"Cell"},{"key":"811_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels, S. et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord. 22, 63 (2022).","journal-title":"BMC Endocr. Disord."},{"key":"811_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"811_CR5","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.cgh.2015.07.029","volume":"13","author":"A Ahmed","year":"2015","unstructured":"Ahmed, A., Wong, R. J. & Harrison, S. A. Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes. Clin. Gastroenterol. Hepatol. 13, 2062\u20132070 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"811_CR6","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S315724","volume":"15","author":"JM Fraile","year":"2021","unstructured":"Fraile, J. M., Palliyil, S., Barelle, C., Porter, A. J. & Kovaleva, M. Non-alcoholic steatohepatitis (NASH)\u2014a review of a crowded clinical landscape, driven by a complex disease. Drug Des. Devel. Ther. 15, 3997\u20134009 (2021).","journal-title":"Drug Des. Devel. Ther."},{"key":"811_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"811_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15691","volume":"8","author":"M Ogrodnik","year":"2017","unstructured":"Ogrodnik, M. et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 8, 15691 (2017).","journal-title":"Nat. Commun."},{"key":"811_CR9","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.jhepr.2021.100301","volume":"3","author":"AS Meijnikman","year":"2021","unstructured":"Meijnikman, A. S. et al. Evaluating causality of cellular senescence in non-alcoholic fatty liver disease. JHEP Rep. 3, 100301 (2021).","journal-title":"JHEP Rep."},{"key":"811_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.30834","volume":"71","author":"AM Papatheodoridi","year":"2020","unstructured":"Papatheodoridi, A. M., Chrysavgis, L., Koutsilieris, M. & Chatzigeorgiou, A. The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis. Hepatology 71, 363\u2013374 (2020).","journal-title":"Hepatology"},{"key":"811_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15838-0","volume":"11","author":"Y He","year":"2020","unstructured":"He, Y. et al. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity. Nat. Commun. 11, 1996 (2020).","journal-title":"Nat. Commun."},{"key":"811_CR12","doi-asserted-by":"crossref","unstructured":"He, Y., Zheng, G. & Zhou, D. Senolytic drug development. In Senolytics in Disease, Ageing and Longevity (eds Mu\u00f1oz-Espin, D. & Demaria, M.) 3\u201320 (Springer, 2020).","DOI":"10.1007\/978-3-030-44903-2_1"},{"key":"811_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","volume":"61","author":"PD Robbins","year":"2021","unstructured":"Robbins, P. D. et al. Senolytic drugs: reducing senescent cell viability to extend health span. Annu. Rev. Pharmacol. Toxicol. 61, 779\u2013803 (2021).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"811_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78\u201383 (2016).","journal-title":"Nat. Med."},{"key":"811_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775\u2013781 (2017).","journal-title":"Nat. Med."},{"key":"811_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y. et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15, 428\u2013435 (2016).","journal-title":"Aging Cell"},{"key":"811_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.aaf6659","volume":"354","author":"BG Childs","year":"2016","unstructured":"Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472\u2013477 (2016).","journal-title":"Science"},{"key":"811_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"811_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","volume":"99","author":"J Pan","year":"2017","unstructured":"Pan, J. et al. Inhibition of Bcl-2\/xl with ABT-263 selectively kills senescent type II pneumocytes and reverses persistent pulmonary fibrosis induced by ionizing radiation in mice. Int. J. Radiat. Oncol. Biol. Phys. 99, 353\u2013361 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"811_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11190","volume":"7","author":"R Yosef","year":"2016","unstructured":"Yosef, R. et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat. Commun. 7, 11190 (2016).","journal-title":"Nat. Commun."},{"key":"811_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07825-3","volume":"9","author":"Y Ovadya","year":"2018","unstructured":"Ovadya, Y. et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat. Commun. 9, 5435 (2018).","journal-title":"Nat. Commun."},{"key":"811_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/gutjnl-2020-321112","volume":"71","author":"D Kolodkin-Gal","year":"2022","unstructured":"Kolodkin-Gal, D. et al. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions. Gut 71, 345\u2013355 (2022).","journal-title":"Gut"},{"key":"811_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41593-024-01620-8","volume":"27","author":"N Rachmian","year":"2024","unstructured":"Rachmian, N. et al. Identification of senescent, TREM2-expressing microglia in aging and Alzheimer\u2019s disease model mouse brain. Nat. Neurosci. 27, 1116\u20131124 (2024).","journal-title":"Nat. Neurosci."},{"key":"811_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","volume":"16","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi, A., Fairbrother, W. J., Leverson, J. D. & Souers, A. J. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat. Rev. Drug Discov. 16, 273\u2013284 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"811_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","volume":"29","author":"L Gandhi","year":"2011","unstructured":"Gandhi, L. et al. Phase I study of navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J. Clin. Oncol. 29, 909\u2013916 (2011).","journal-title":"J. Clin. Oncol."},{"key":"811_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202\u2013208 (2013).","journal-title":"Nat. Med."},{"key":"811_CR27","doi-asserted-by":"publisher","first-page":"279ra40","DOI":"10.1126\/scitranslmed.aaa4642","volume":"7","author":"JD Leverson","year":"2015","unstructured":"Leverson, J. D. et al. Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci. Transl. Med. 7, 279ra40 (2015).","journal-title":"Sci. Transl. Med."},{"key":"811_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27210-x","volume":"12","author":"D Lv","year":"2021","unstructured":"Lv, D. et al. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat. Commun. 12, 6896 (2021).","journal-title":"Nat. Commun."},{"key":"811_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","volume":"46","author":"M Fujii","year":"2013","unstructured":"Fujii, M. et al. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med. Mol. Morphol. 46, 141\u2013152 (2013).","journal-title":"Med. Mol. Morphol."},{"key":"811_CR30","first-page":"4849","volume":"34","author":"K Takakura","year":"2014","unstructured":"Takakura, K. et al. Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice. Anticancer Res. 34, 4849\u20134856 (2014).","journal-title":"Anticancer Res."},{"key":"811_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644\u2013658 (2015).","journal-title":"Aging Cell"},{"key":"811_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657\u2013667 (2008).","journal-title":"Cell"},{"key":"811_CR33","doi-asserted-by":"publisher","first-page":"112689","DOI":"10.1016\/j.yexcr.2021.112689","volume":"405","author":"H Yu","year":"2021","unstructured":"Yu, H. et al. Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway. Exp. Cell. Res. 405, 112689 (2021).","journal-title":"Exp. Cell. Res."},{"key":"811_CR34","doi-asserted-by":"publisher","first-page":"12526","DOI":"10.3748\/wjg.v20.i35.12526","volume":"20","author":"WK Saeed","year":"2014","unstructured":"Saeed, W. K. & Jun, D. W. Necroptosis: an emerging type of cell death in liver diseases. World J. Gastroenterol. 20, 12526\u201312532 (2014).","journal-title":"World J. Gastroenterol."},{"key":"811_CR35","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","volume":"67","author":"O Krenkel","year":"2018","unstructured":"Krenkel, O. et al. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67, 1270\u20131283 (2018).","journal-title":"Hepatology"},{"key":"811_CR36","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/acel.13512","volume":"20","author":"S Mohammed","year":"2021","unstructured":"Mohammed, S. et al. Necroptosis contributes to chronic inflammation and fibrosis in aging liver. Aging Cell 20, e13512 (2021).","journal-title":"Aging Cell"},{"key":"811_CR37","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.7150\/thno.71400","volume":"12","author":"R Guo","year":"2022","unstructured":"Guo, R. et al. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation. Theranostics 12, 5220\u20135236 (2022).","journal-title":"Theranostics"},{"key":"811_CR38","doi-asserted-by":"publisher","first-page":"e13676","DOI":"10.1111\/acel.13676","volume":"21","author":"N Thadathil","year":"2022","unstructured":"Thadathil, N. et al. Senolytic treatment reduces cell senescence and necroptosis in Sod1 knockout mice that is associated with reduced inflammation and hepatocellular carcinoma. Aging Cell 21, e13676 (2022).","journal-title":"Aging Cell"},{"key":"811_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fonc.2018.00533","volume":"8","author":"A Slomp","year":"2018","unstructured":"Slomp, A. & Peperzak, V. Role and regulation of pro-survival BCL-2 proteins in multiple myeloma. Front. Oncol. 8, 533 (2018).","journal-title":"Front. Oncol."},{"key":"811_CR40","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ijrobp.2019.11.029","volume":"106","author":"MR Jackson","year":"2020","unstructured":"Jackson, M. R. et al. Mesothelioma cells depend on the antiapoptotic protein Bcl-xL for survival and are sensitized to ionizing radiation by BH3-mimetics. Int. J. Radiat. Oncol. Biol. Phys. 106, 867\u2013877 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"811_CR41","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen, X. & Calvisi, D. F. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am. J. Pathol. 184, 912\u2013923 (2014).","journal-title":"Am. J. Pathol."},{"key":"811_CR42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2017.05.015","volume":"169","author":"S He","year":"2017","unstructured":"He, S. & Sharpless, N. E. Senescence in health and disease. Cell 169, 1000\u20131011 (2017).","journal-title":"Cell"},{"key":"811_CR43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","volume":"15","author":"D Mu\u00f1oz-Esp\u00edn","year":"2014","unstructured":"Mu\u00f1oz-Esp\u00edn, D. & Serrano, M. Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15, 482\u2013496 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"811_CR44","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","volume":"155","author":"D Mu\u00f1oz-Esp\u00edn","year":"2013","unstructured":"Mu\u00f1oz-Esp\u00edn, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104\u20131118 (2013).","journal-title":"Cell"},{"key":"811_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2013.10.041","volume":"155","author":"M Storer","year":"2013","unstructured":"Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119\u20131130 (2013).","journal-title":"Cell"},{"key":"811_CR46","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31, 722\u2013733 (2014).","journal-title":"Dev. Cell"},{"key":"811_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1126\/science.abf3326","volume":"378","author":"NS Reyes","year":"2022","unstructured":"Reyes, N. S. et al. Sentinel p16INK4a+ cells in the basement membrane form a reparative niche in the lung. Science 378, 192\u2013201 (2022).","journal-title":"Science"},{"key":"811_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nm.4054","volume":"22","author":"A Helman","year":"2016","unstructured":"Helman, A. et al. p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion. Nat. Med. 22, 412\u2013420 (2016).","journal-title":"Nat. Med."},{"key":"811_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97\u2013101 (2013).","journal-title":"Nature"},{"key":"811_CR50","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1309\/AJCPWMX47TREYWZG","volume":"133","author":"M Sasaki","year":"2010","unstructured":"Sasaki, M. et al. Bile ductular cells undergoing cellular senescence increase in chronic liver diseases along with fibrous progression. Am. J. Clin. Pathol. 133, 212\u2013223 (2010).","journal-title":"Am. J. Clin. Pathol."},{"key":"811_CR51","doi-asserted-by":"publisher","first-page":"11152","DOI":"10.18632\/aging.103492","volume":"12","author":"L Grosse","year":"2020","unstructured":"Grosse, L. & Bulavin, D. V. LSEC model of aging. Aging 12, 11152\u201311160 (2020).","journal-title":"Aging"},{"key":"811_CR52","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.15252\/embj.201695553","volume":"36","author":"R Yosef","year":"2017","unstructured":"Yosef, R. et al. p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. EMBO J. 36, 2280\u20132295 (2017).","journal-title":"EMBO J."},{"key":"811_CR53","doi-asserted-by":"publisher","first-page":"e22125","DOI":"10.1096\/fj.202101426R","volume":"36","author":"Y Wan","year":"2022","unstructured":"Wan, Y. et al. Endothelial dysfunction in pathological processes of chronic liver disease during aging. FASEB J. 36, e22125 (2022).","journal-title":"FASEB J."},{"key":"811_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-021-00731-0","volume":"19","author":"M Raffaele","year":"2021","unstructured":"Raffaele, M. et al. Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin. Cell Commun. Signal. 19, 44 (2021).","journal-title":"Cell Commun. Signal."},{"key":"811_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41556-020-0511-2","volume":"22","author":"F Li","year":"2020","unstructured":"Li, F. et al. FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat. Cell Biol. 22, 728\u2013739 (2020).","journal-title":"Nat. Cell Biol."},{"key":"811_CR56","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mad.2021.111572","volume":"199","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Hepatic stellate cell senescence in liver fibrosis: characteristics, mechanisms and perspectives. Mech. Ageing Dev. 199, 111572 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"811_CR57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.18632\/aging.101787","volume":"11","author":"W Li","year":"2019","unstructured":"Li, W., He, Y., Zhang, R., Zheng, G. & Zhou, D. The curcumin analog EF24 is a novel senolytic agent. Aging 11, 771\u2013782 (2019).","journal-title":"Aging"},{"key":"811_CR58","doi-asserted-by":"publisher","first-page":"e13117","DOI":"10.1111\/acel.13117","volume":"19","author":"Y He","year":"2020","unstructured":"He, Y. et al. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity. Aging Cell 19, e13117 (2020).","journal-title":"Aging Cell"},{"key":"811_CR59","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.1016\/j.xpro.2020.100064","volume":"1","author":"M Tripathi","year":"2020","unstructured":"Tripathi, M., Yen, P. M. & Singh, B. K. Protocol to generate senescent cells from the mouse hepatic cell line AML12 to study hepatic aging. STAR Protoc. 1, 100064 (2020).","journal-title":". STAR Protoc."},{"key":"811_CR60","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/hep.28601","volume":"64","author":"J Tao","year":"2016","unstructured":"Tao, J. et al. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant \u03b2-catenin. Hepatology 64, 1587\u20131605 (2016).","journal-title":"Hepatology"},{"key":"811_CR61","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","volume":"25","author":"S Khan","year":"2019","unstructured":"Khan, S. et al. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat. Med. 25, 1938\u20131947 (2019).","journal-title":"Nat. Med."},{"key":"811_CR62","doi-asserted-by":"publisher","first-page":"103009","DOI":"10.1016\/j.xpro.2024.103009","volume":"5","author":"OG Idelfonso-Garc\u00eda","year":"2024","unstructured":"Idelfonso-Garc\u00eda, O. G. et al. Protocol to detect senescence-associated \u03b2-galactosidase and immunoperoxidase activity in fresh-frozen murine tissues. STAR Protoc. 5, 103009 (2024).","journal-title":"STAR Protoc."},{"key":"811_CR63","doi-asserted-by":"crossref","unstructured":"Quintas Coentro, J. et al. Collagen quantification in tissue specimens. In Fibrosis: Methods and Protocols (ed Ritti\u00e9, L.) 341\u2013350 (Springer, 2017).","DOI":"10.1007\/978-1-4939-7113-8_22"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00811-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:52:52Z","timestamp":1742381572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00811-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1038\/s43587-025-00811-7","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.Y., Y.H., P.Z., W.H., G.Z., L.P. and D.Z. are inventors on patents for the use of BCL-xL PROTACs as anti-tumor agents and senolytics. R.H., G.Z. and D.Z. are cofounders of and have equity in Dialectic Therapeutics, which develops BCL-xL\/2 PROTACs to treat cancer. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}